Loading
Latest filing published 05 Jan 2023 for Salarius Pharmaceuticals, Inc..
No signal scores available.
Our data holds just one disclosure by Paul Lammers, dated 5 January 2023, reporting a share grant in Salarius Pharmaceuticals, Inc. Further filings will be added here. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration